Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sulodexide in elderly patients with diabetic nephropathy
ChiCTR-IPC-15007029Phase 4Not yet recruiting
- Sponsor
- Zhejiang Hospital
- Start
- Oct 2015
- Countries
- 1
01
Overview
Phase 4, open-label trial of sulodexide in diabetic glomerulosclerosis (2 arms), sponsored by Zhejiang Hospital. Primary endpoint: 24-hour urinary protein excretion rate. Planned start Oct 2015; status: not yet recruiting.
02
Drugs
sulodexide
03
Conditions
diabetic glomerulosclerosis
Beyond the preview
Go deeper on ChiCTR-IPC-15007029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPC-15007029.